tiprankstipranks
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
US Market
REPCF
RepliCel Life Sciences
RESEARCH TOOLSreports

RepliCel Life Sciences (REPCF) Income Statement

22 Followers

RepliCel Life Sciences Income Statement

Last quarter (Q4 2025), RepliCel Life Sciences's total revenue was C$353.44K, an increase of 475.20% from the same quarter last year. In Q4, RepliCel Life Sciences's net income was C$7.87M. See RepliCel Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Mar 24Mar 23Mar 22
Total Revenue
C$ 353.44KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Gross Profit
C$ 0.00C$ 353.74KC$ 352.26KC$ 353.74KC$ 353.74K
Operating Expenses
C$ 115.60KC$ 713.82KC$ 1.74MC$ 1.75MC$ 2.65M
Depreciation and Amortization
C$ 0.00C$ 541.00C$ 1.47KC$ 839.00C$ 1.15K
EBITDA
C$ 237.84KC$ -359.46KC$ -1.39MC$ -736.00KC$ -4.07M
Operating Income
C$ 237.84KC$ -360.00KC$ -1.39MC$ -1.39MC$ -2.30M
Other Income/Expenses
C$ -484.87KC$ 262.80KC$ 1.07MC$ 649.47KC$ -1.77M
Pretax Income
C$ -247.03KC$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07M
Net Income
C$ -401.63KC$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07M
Per Share Metrics
Basic EPS
C$ >-0.01C$ >-0.01C$ >-0.01C$ -0.02C$ -0.13
Diluted EPS
C$ >-0.01C$ >-0.01C$ >-0.01C$ -0.02C$ -0.13
Weighted Average Shares Outstanding
 70.01M 62.29M 59.24M 37.77M 32.49M
Weighted Average Shares Outstanding (Diluted)
 70.01M 62.25M 59.24M 37.77M 32.49M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History